Treating Major Depression With Yoga Mono-therapy
Treating Major Depression With Yoga Mono-therapy: 12-Week Randomized Controlled Trial
University of California, San Francisco
180 participants
Oct 25, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
Eligibility
Inclusion Criteria4
- years of age or older
- Able to give voluntary, informed consent
- English-speaking
- Diagnosis of clinical depression
Exclusion Criteria4
- Current use of antidepressant medication
- Current engagement in psychotherapy
- Current pregnancy
- Significant medical issues interfering with yoga practice
Interventions
90-minute group yoga classes twice weekly for 12 weeks.
90-minute group education classes twice weekly for 12 weeks to learn holistic healthcare modules.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06091527